by Mente Team | Sep 7, 2020 | News
News and Press Releases Neurotech secures a new European commercial agreement with Brain Therapeutics in Greece as Mente Autism therapy distribution partner Perth, Australia, Malta & Athens, Greece – Neurotech International Limited (ASX: NTI) (“Neurotech”...
by Mente Team | Apr 14, 2020 | News
News and Press Releases Neurotech International’s At Home Therapy Device Mente receives CE mark renewal for use with ASD Children Neurotech International Limited (ASX: NTI) (“Neurotech” or the “Company”), developer of quality medical solutions in the neuroscience...
by Mente Team | Mar 30, 2020 | News
News and Press Releases Mente, the world’s only clinically proven stay at home therapy for ASD children, continues to build awareness in Europe Neurotech International Limited (ASX: NTI) is pleased to announce it has now been added to the UK’s National Autistic...
by Mente Team | Feb 25, 2020 | News
News and Press Releases New Mente autism therapy referral program Malta and Perth, Australia – Neurotech International Limited (ASX: NTI) is pleased to announce an innovative clinic led initiative, being a new referral model that provides each Mente clinic with...
by Mente Team | Dec 19, 2019 | News
News and Press Releases Neurotech Announces Mente Partnership with the Australian Neurofeedback Institute New qEEG service enhances support for clinics using or recommending Mente in Australia Malta and Perth, Australia – Neurotech International Limited (ASX:...
by Mente Team | Dec 19, 2019 | News
News and Press Releases Neurotech signs exclusive agreement with Holy Stone Healthcare expanding distribution of Mente and support for children with autism in Taiwan Malta and Perth, Australia – Neurotech International Limited (ASX: NTI) is pleased to announce...
Recent Comments